4.5 • 645 Ratings
🗓️ 7 August 2017
⏱️ 55 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | The Latter Day Lives podcast is not owned or operated by the Church of Jesus Christ of Latter-day Saints. |
0:15.1 | Any opinions expressed or implied in this recording are solely those of the host and guests, |
0:19.9 | and not of any specific organization |
0:21.7 | unless otherwise stated. |
0:30.0 | Hello, friends, and welcome to the Latter-day Lives podcast. I'm Sean Rupier. I'm your host of the show. |
0:35.6 | Welcome to episode three. We've got a really |
0:38.4 | great show for you today. Our guest today is an LDS icon. He's an actor. He is a comedian. |
0:46.1 | He is a writer and he is a very well-recognized public figure. A little word of caution. |
0:53.1 | He is going to be speaking very openly today in our interview |
0:56.8 | about trials that he's had, including drug abuse. |
1:00.5 | So if you are listening with children, parental guidance is suggested, though he does |
1:04.3 | not go into any deep detail of anything inappropriate. |
1:08.7 | But it's a great conversation with an incredible guy. And so without any |
1:13.1 | further ado, here is the conversation. |
1:25.9 | All right. Today on the podcast, we have a very special guest, a man who's been a friend of |
1:31.1 | mine for a very long time, a very talented guy. |
1:34.9 | Please welcome Mr. Michael Berklin. |
1:38.1 | How are you? |
1:39.0 | Good. |
1:39.3 | How are you? |
1:39.7 | Good. |
1:40.0 | Or I should say Mike B. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Latter Day Lives - Talking with Latter Day Saints, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Latter Day Lives - Talking with Latter Day Saints and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.